Literature DB >> 14812396

The treatment of pulmonary tuberculosis with the thiosemicarbazones.

S J SHANE, C RILEY, J H LAURIE, M BOUTILIER.   

Abstract

Entities:  

Keywords:  THIOSEMICARBAZONES; TUBERCULOSIS, PULMONARY-ANTIBIOTIC AND CHEMOTHERAPY

Mesh：

Substances：

Year:  1951        PMID： 14812396      PMCID： PMC1822024     

Source DB:  PubMed          Journal:  Can Med Assoc J        ISSN： 0008-4409            Impact factor:   8.262


× No keyword cloud information.
  7 in total

1.  Chemical studies on thiosemicarbazones with particular reference to antituberculous activity.

Authors:  R BEHNISCH; F MIETZSCH; H SCHMIDT
Journal:  Am Rev Tuberc       Date:  1950-01

2.  Thiosemicarbazone therapy of tuberculosis in humans.

Authors:  H C HINSHAW; W McDERMOTT
Journal:  Am Rev Tuberc       Date:  1950-01

3.  Investigations on the antituberculous activity of the thiosemicarbazones in vitro and in vivo.

Authors:  G DOMAGK
Journal:  Am Rev Tuberc       Date:  1950-01

4.  The present status of the chemotherapy of tuberculosis with conteben a substance of the thiosemicarbazone series; a review.

Authors:  A MERTENS; R BUNGE
Journal:  Am Rev Tuberc       Date:  1950-01

5.  Human pharmacology of p-formylacetanilide thiosemicarbazone (myvizone).

Authors:  G SIMMONS; L B HOBSON; A RESNICK; R DeNICOLA; R H BENNETT
Journal:  Am Rev Tuberc       Date:  1950-08

6.  The effect of 4-acetylaminobenzal thiosemicarbazone (tibione) on experimental tuberculosis in guinea pigs.

Authors:  D M SPAIN; W G CHILDRESS; J S FISHLER
Journal:  Am Rev Tuberc       Date:  1950-08

7.  Agranulocytosis during therapy with the antihistaminic agent methaphenilene.

Authors:  T G DRAKE
Journal:  J Am Med Assoc       Date:  1950-02-18
  7 in total
  1 in total

1.  Detection of inhibitors of phenotypically drug-tolerant Mycobacterium tuberculosis using an in vitro bactericidal screen.

Authors:  Ian M Bassett; Shichun Lun; William R Bishai; Haidan Guo; Joanna R Kirman; Mudassar Altaf; Ronan F O'Toole
Journal:  J Microbiol       Date:  2013-06-25       Impact factor: 3.422
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.